Pharmacovigilance

Explore long-term safety monitoring of biosimilars after market approval.Discuss adverse-event reporting, signal detection, traceability, and risk management.Examine the role of real-world data in identifying potential safety signals.Highlight global approaches to post-marketing surveillance.Focus on maintaining patient safety throughout the product lifecycle.

 

    Related Conference of Pharmacovigilance

    August 27-28, 2026

    30th Global Congress on Biotechnology

    Berlin, Germany
    September 21-22, 2026

    6th International Conference on Biomedicine & Pharmacotherapy

    Rome, Italy
    November 16-17, 2026

    8th International Conference on Biochemistry

    Tokyo, Japan
    November 25-26, 2026

    30th World Congress on Biotechnology

    Rome, Italy
    December 01-02, 2026

    21st World Congress on Biomarkers, Cancer Therapy & Clinical Research

    Dubai, UAE
    January 18-19, 2027

    7th Annual Congress on Antibiotics and Bacterial Infections

    Paris, France
    January 20-21, 2027

    33nd Asia Pacific Biotechnology Congress

    Dubai, UAE
    March 15-16, 2027

    8th Annual Congress on Biosimilars and Future Biotherapeutics

    San Francisco, USA
    April 27-28, 2027

    30th European Biotechnology Congress

    Paris, France
    June 07-08, 2027

    42nd International Conference on Next-Gen Biotechnology and Applications

    Atlanta, USA
    June 07-08, 2027

    28th Biotechnology Congress: Research & Innovations

    Atlanta, USA

    Pharmacovigilance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in